LUCD Lucid Diagnostics: Wutah pendapatan triwulanan

Simbol lan logo merek Lucid Diagnostics, Inc. (LUCD)

The success of Lucid Diagnostics Inc. (LUCD) relies on the recognition of its methodologies by associations and insurance coverage for esophageal cancer tests. Quarterly sales growth dynamics demonstrate business adaptation, where the latest parameter stands at -0.70. The integration of diagnostics into gastroenterologist protocols ensures a steady stream of orders and margins. However, high promotion costs are creating a cash gap that is depleting the company's cash reserves.

LUCD (Lucid Diagnostics, Inc) riwayat Wutah dodolan kuartal marang kuartal saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Lucid Diagnostics (LUCD)

- rega saham lan target rega konsensus:
Analisis fundamental perusahaan:Lucid Diagnostics, Inc (LUCD)
Produk sing diprodhuksi luciddx.com

The lack of alternatives for the Lucid Diagnostics Inc. (LUCD) molecular esophageal cancer test provides the company with exceptional pricing power. This market dominance is directly reflected in sales dynamics, measured by the estimated revenue change for the current quarter relative to the same period last year. This metric assesses the pace of business scaling, allowing for the identification of asset overheating during sharp growth acceleration. Analyzing the quarterly revenue growth rate helps investors recognize the risk of a price correction in a timely manner should the trend shift.

Pesaing Lucid Diagnostics Inc. (LUCD)

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|Wutah dodolan triwulanan Cologuard|RVTY (Revvity Corp) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Bio-Rad Laboratories Inc|Wutah dodolan triwulanan NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal QuidelOrtho Inc. QDEL|Wutah pendapatan triwulanan OPKO Health Inc OPK|CareDx Inc - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan MRVI (Maravai)|FLGT: Wutah pendapatan triwulanan|LAB (Standard BioTools Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Cytek Biosciences Inc|Tingkat wutah pendapatan sajrone kuartal OraSure OSUR|Wutah dodolan triwulanan XGN (Exagen Diagnostics)|Tingkat wutah dodolan sajrone kuartal MDxHealth Inc.|Wutah pendapatan kuartal marang kuartal Prenetics PRE|Insight Molecular (IMDX) - Tingkat wutah pendapatan sajrone kuartal|Trinity Biotech Corp - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal ProPhase PRPH|AIMD: Wutah pendapatan triwulanan|CODX - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Heart Test Laboratories, Inc.|Wutah pendapatan kuartal marang kuartal BMRA|Wutah pendapatan triwulanan CDIO|Onconetix - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal viraxbiolabs.com VRAX|Tingkat wutah dodolan sajrone kuartal Bluejay (BJDX)|AWH: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ENZ (Enzo)|Wutah dodolan kuartal marang kuartal Fresh2 (FRES)|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)